AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Pattanayak SP, Darawshi O, Hajihassani O, Winter JM, Weiler N, Ott M, Rothweiler F, Cinatl J Jr, Michaelis M, Lindner DJ, Green TD, Krassovskaia P, Aruleba RT, Fisher-Wellman KH, Mears JA, Wald D, Eriksson LA, Tirosh B

Open source

DOI: 10.1186/s12943-026-02689-4
Published: 2026 May 27
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02689-4,
  title = {AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.},
  author = {Pattanayak SP and Darawshi O and Hajihassani O and Winter JM and Weiler N and Ott M and Rothweiler F and Cinatl J Jr and Michaelis M and Lindner DJ and Green TD and Krassovskaia P and Aruleba RT and Fisher-Wellman KH and Mears JA and Wald D and Eriksson LA and Tirosh B},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02689-4},
  url = {https://doi.org/10.1186/s12943-026-02689-4}
}

RIS

TY  - JOUR
TI  - AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.
AU  - Pattanayak SP
AU  - Darawshi O
AU  - Hajihassani O
AU  - Winter JM
AU  - Weiler N
AU  - Ott M
AU  - Rothweiler F
AU  - Cinatl J Jr
AU  - Michaelis M
AU  - Lindner DJ
AU  - Green TD
AU  - Krassovskaia P
AU  - Aruleba RT
AU  - Fisher-Wellman KH
AU  - Mears JA
AU  - Wald D
AU  - Eriksson LA
AU  - Tirosh B
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02689-4
UR  - https://doi.org/10.1186/s12943-026-02689-4
ER  -

APA

SP, P., O, D., O, H., JM, W., N, W., M, O., F, R., Jr, C. J., M, M., DJ, L., TD, G., P, K., RT, A., KH, F., JA, M., D, W., LA, E., & B, T. (2026). AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.. Molecular cancer. https://doi.org/10.1186/s12943-026-02689-4

Source records

pubmed · retrieved 2026-09-25T22:19:09.928Z